Lyrica CR is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Parke-davis Div Of Pfizer Inc. The primary component is Pregabalin.
| Product ID | 0071-1029_7ae64cb2-1b1b-456e-8c93-7fc31f0d3113 |
| NDC | 0071-1029 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Lyrica CR |
| Generic Name | Pregabalin |
| Dosage Form | Tablet, Film Coated, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-01-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA209501 |
| Labeler Name | Parke-Davis Div of Pfizer Inc |
| Substance Name | PREGABALIN |
| Active Ingredient Strength | 330 mg/1 |
| DEA Schedule | CV |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2018-01-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA209501 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-01-01 |
| Ingredient | Strength |
|---|---|
| PREGABALIN | 330 mg/1 |
| SPL SET ID: | 2d832165-3d98-497c-84b0-2d9ae3f838f9 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0071-1026 | Lyrica CR | Lyrica CR |
| 0071-1027 | Lyrica CR | Lyrica CR |
| 0071-1029 | Lyrica CR | Lyrica CR |
| 63539-024 | Lyrica CR | Lyrica CR |
| 0071-1012 | Lyrica | PREGABALIN |
| 0071-1013 | Lyrica | PREGABALIN |
| 0071-1014 | Lyrica | PREGABALIN |
| 0071-1015 | Lyrica | PREGABALIN |
| 0071-1016 | Lyrica | PREGABALIN |
| 0071-1017 | Lyrica | PREGABALIN |
| 0071-1018 | Lyrica | PREGABALIN |
| 0071-1019 | Lyrica | PREGABALIN |
| 0071-1020 | Lyrica | PREGABALIN |